{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:41:10Z","timestamp":1792806070949,"version":"4.5.0"},"reference-count":95,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:00:00Z","timestamp":1751068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council, GlycoCell Engineering Biology Mission Hub","doi-asserted-by":"publisher","award":["BB\/Y008472\/1"],"award-info":[{"award-number":["BB\/Y008472\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council, GlycoCell Engineering Biology Mission Hub","doi-asserted-by":"publisher","award":["BB\/W006146\/1"],"award-info":[{"award-number":["BB\/W006146\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council, GlycoCell Engineering Biology Mission Hub","doi-asserted-by":"publisher","award":["BB\/W005816\/1"],"award-info":[{"award-number":["BB\/W005816\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council, GlycoCell Engineering Biology Mission Hub","doi-asserted-by":"publisher","award":["EP\/Y530542\/1"],"award-info":[{"award-number":["EP\/Y530542\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council, GlycoCell Engineering Biology Mission Hub","doi-asserted-by":"publisher","award":["221589\/Z\/20\/Z"],"award-info":[{"award-number":["221589\/Z\/20\/Z"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council, GlycoCell Engineering Biology Mission Hub","doi-asserted-by":"publisher","award":["221803\/Z\/20\/Z"],"award-info":[{"award-number":["221803\/Z\/20\/Z"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council, GlycoCell Engineering Biology Mission Hub","doi-asserted-by":"publisher","award":["RF-2023-V02"],"award-info":[{"award-number":["RF-2023-V02"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"Engineering Physical Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/Y008472\/1"],"award-info":[{"award-number":["BB\/Y008472\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"Engineering Physical Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/W006146\/1"],"award-info":[{"award-number":["BB\/W006146\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"Engineering Physical Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/W005816\/1"],"award-info":[{"award-number":["BB\/W005816\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"Engineering Physical Sciences Research Council","doi-asserted-by":"publisher","award":["EP\/Y530542\/1"],"award-info":[{"award-number":["EP\/Y530542\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"Engineering Physical Sciences Research Council","doi-asserted-by":"publisher","award":["221589\/Z\/20\/Z"],"award-info":[{"award-number":["221589\/Z\/20\/Z"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"Engineering Physical Sciences Research Council","doi-asserted-by":"publisher","award":["221803\/Z\/20\/Z"],"award-info":[{"award-number":["221803\/Z\/20\/Z"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"Engineering Physical Sciences Research Council","doi-asserted-by":"publisher","award":["RF-2023-V02"],"award-info":[{"award-number":["RF-2023-V02"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Innovator Award","doi-asserted-by":"publisher","award":["BB\/Y008472\/1"],"award-info":[{"award-number":["BB\/Y008472\/1"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Innovator Award","doi-asserted-by":"publisher","award":["BB\/W006146\/1"],"award-info":[{"award-number":["BB\/W006146\/1"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Innovator Award","doi-asserted-by":"publisher","award":["BB\/W005816\/1"],"award-info":[{"award-number":["BB\/W005816\/1"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Innovator Award","doi-asserted-by":"publisher","award":["EP\/Y530542\/1"],"award-info":[{"award-number":["EP\/Y530542\/1"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Innovator Award","doi-asserted-by":"publisher","award":["221589\/Z\/20\/Z"],"award-info":[{"award-number":["221589\/Z\/20\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Innovator Award","doi-asserted-by":"publisher","award":["221803\/Z\/20\/Z"],"award-info":[{"award-number":["221803\/Z\/20\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Innovator Award","doi-asserted-by":"publisher","award":["RF-2023-V02"],"award-info":[{"award-number":["RF-2023-V02"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Investigator Award","doi-asserted-by":"publisher","award":["BB\/Y008472\/1"],"award-info":[{"award-number":["BB\/Y008472\/1"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Investigator Award","doi-asserted-by":"publisher","award":["BB\/W006146\/1"],"award-info":[{"award-number":["BB\/W006146\/1"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Investigator Award","doi-asserted-by":"publisher","award":["BB\/W005816\/1"],"award-info":[{"award-number":["BB\/W005816\/1"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Investigator Award","doi-asserted-by":"publisher","award":["EP\/Y530542\/1"],"award-info":[{"award-number":["EP\/Y530542\/1"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Investigator Award","doi-asserted-by":"publisher","award":["221589\/Z\/20\/Z"],"award-info":[{"award-number":["221589\/Z\/20\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Investigator Award","doi-asserted-by":"publisher","award":["221803\/Z\/20\/Z"],"award-info":[{"award-number":["221803\/Z\/20\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Investigator Award","doi-asserted-by":"publisher","award":["RF-2023-V02"],"award-info":[{"award-number":["RF-2023-V02"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"name":"RIGHT Foundation","award":["BB\/Y008472\/1"],"award-info":[{"award-number":["BB\/Y008472\/1"]}]},{"name":"RIGHT Foundation","award":["BB\/W006146\/1"],"award-info":[{"award-number":["BB\/W006146\/1"]}]},{"name":"RIGHT Foundation","award":["BB\/W005816\/1"],"award-info":[{"award-number":["BB\/W005816\/1"]}]},{"name":"RIGHT Foundation","award":["EP\/Y530542\/1"],"award-info":[{"award-number":["EP\/Y530542\/1"]}]},{"name":"RIGHT Foundation","award":["221589\/Z\/20\/Z"],"award-info":[{"award-number":["221589\/Z\/20\/Z"]}]},{"name":"RIGHT Foundation","award":["221803\/Z\/20\/Z"],"award-info":[{"award-number":["221803\/Z\/20\/Z"]}]},{"name":"RIGHT Foundation","award":["RF-2023-V02"],"award-info":[{"award-number":["RF-2023-V02"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Glycoconjugate vaccines, consisting of a protein component covalently linked to a glycan antigen, have led to a significant reduction in the global occurrence of bacterial meningitis and pneumonia. They provide robust, lasting immunity in all age groups. However, their production by traditional chemical conjugation approaches has drawbacks in terms of complexity, cost, and lack of flexibility in design, which explains their limited application to a few pathogenic bacteria in the past four decades. Protein glycan coupling technology (PGCT) or bioconjugation, where glycoconjugates are produced in purpose-engineered bacterial cells, is a useful alternative to chemical conjugation and promises an array of low-cost custom-made glycoconjugate vaccines with vast protein glycan combinations. The technology has undergone significant development since its inception, and new advances and refinements continually drive the field forward. Several bioconjugate vaccines are currently in clinical trials, demonstrating the potential of the technology. We will review the wide applicability of bioconjugation and recent developments in each of the components of the technology, namely, glycan expression, protein selection, and the coupling of selected glycan with proteins, all within custom-designed E. coli cells. These advances promise to deliver effective glycoconjugate vaccines for multiple unmet medical needs.<\/jats:p>","DOI":"10.3390\/vaccines13070703","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T07:42:06Z","timestamp":1751355726000},"page":"703","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Recent Advances in Bioconjugate Vaccine Development"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6140-9489","authenticated-orcid":false,"given":"Brendan W.","family":"Wren","sequence":"first","affiliation":[{"name":"Department of Infection Biology, London School of Hygiene and Tropical Medicine, Keppel St, London WC1E 7HT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine L.","family":"Hall","sequence":"additional","affiliation":[{"name":"Department of Infection Biology, London School of Hygiene and Tropical Medicine, Keppel St, London WC1E 7HT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2734-4036","authenticated-orcid":false,"given":"Vanessa S.","family":"Terra","sequence":"additional","affiliation":[{"name":"Department of Infection Biology, London School of Hygiene and Tropical Medicine, Keppel St, London WC1E 7HT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Harrison","sequence":"additional","affiliation":[{"name":"Department of Infection Biology, London School of Hygiene and Tropical Medicine, Keppel St, London WC1E 7HT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1783-6889","authenticated-orcid":false,"given":"Elizabeth","family":"Atkins","sequence":"additional","affiliation":[{"name":"Department of Infection Biology, London School of Hygiene and Tropical Medicine, Keppel St, London WC1E 7HT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7368-3867","authenticated-orcid":false,"given":"Fauzy","family":"Nasher","sequence":"additional","affiliation":[{"name":"Department of Infection Biology, London School of Hygiene and Tropical Medicine, Keppel St, London WC1E 7HT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4418-6957","authenticated-orcid":false,"given":"Ian J.","family":"Passmore","sequence":"additional","affiliation":[{"name":"Department of Infection Biology, London School of Hygiene and Tropical Medicine, Keppel St, London WC1E 7HT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00006454-198708000-00040","article-title":"Capsular polysaccharide of Haemophilus influenzae type B as a vaccine","volume":"6","author":"Parke","year":"1987","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/nm.2535","article-title":"A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design","volume":"17","author":"Avci","year":"2011","journal-title":"Nat. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"eaat4615","DOI":"10.1126\/scitranslmed.aat4615","article-title":"Glycoconjugate vaccines: Principles and mechanisms","volume":"10","author":"Rappuoli","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1084\/jem.152.2.361","article-title":"Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates","volume":"152","author":"Schneerson","year":"1980","journal-title":"J. Exp. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(13)61612-8","article-title":"Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: A community study","volume":"383","author":"Daugla","year":"2014","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1016\/j.vaccine.2013.04.085","article-title":"Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults","volume":"31","author":"Jackson","year":"2013","journal-title":"Vaccine"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1016\/S0140-6736(17)32149-9","article-title":"Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: A randomised controlled, phase 2b trial","volume":"390","author":"Jin","year":"2017","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.4161\/hv.7.10.16794","article-title":"13-valent pneumococcal conjugate vaccine (PCV13). Hum","volume":"7","author":"Jefferies","year":"2011","journal-title":"Vaccin."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1080\/14760584.2019.1657012","article-title":"Glycoconjugate vaccines: Current approaches towards faster vaccine design","volume":"18","author":"Micoli","year":"2019","journal-title":"Expert Rev. Vaccines"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1046\/j.1365-2958.1999.01415.x","article-title":"Evidence for a system of general protein glycosylation in Campylobacter jejuni","volume":"32","author":"Szymanski","year":"1999","journal-title":"Mol. Microbiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/35001088","article-title":"The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences","volume":"403","author":"Parkhill","year":"2000","journal-title":"Nature"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1126\/science.298.5599.1790","article-title":"N-linked glycosylation in Campylobacter jejuni and its functional transfer into E. coli","volume":"298","author":"Wacker","year":"2002","journal-title":"Science"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1038\/sj.emboj.7601087","article-title":"Definition of the bacterial N-glycosylation site consensus sequence","volume":"25","author":"Kowarik","year":"2006","journal-title":"EMBO J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1073\/pnas.0500044102","article-title":"Engineering N-linked protein glycosylation with diverse O antigen lipopolysaccharide structures in Escherichia coli","volume":"102","author":"Feldman","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"7088","DOI":"10.1073\/pnas.0509207103","article-title":"Substrate specificity of bacterial oligosaccharyltransferase suggests a common transfer mechanism for the bacterial and eukaryotic systems","volume":"103","author":"Wacker","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2217\/fmb.09.10","article-title":"N-Linked Glycosylation in Bacteria: An Unexpected Application","volume":"4","author":"Langdon","year":"2009","journal-title":"Future Microbiol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Bentley, S.D., Aanensen, D.M., Mavroidi, A., Saunders, D., Rabbinowitsch, E., Collins, M., Donohoe, K., Harris, D., Murphy, L., and Quail, M.A. (2006). Genetic Analysis of the Capsular Biosynthetic Locus from All 90 Pneumococcal Serotypes. PLoS Genet., 2.","DOI":"10.1371\/journal.pgen.0020031"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Wantuch, P.L., Knoot, C.J., Robinson, L.S., Vinogradov, E., Scott, N.E., Harding, C.M., and Rosen, D.A. (2023). Capsular polysaccharide inhibits vaccine-induced O-antigen antibody binding and function across both classical and hypervirulent K2:O1 strains of Klebsiella pneumoniae. PLoS Pathog., 19.","DOI":"10.1371\/journal.ppat.1011367"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Patro, L.P.P., Sudhakar, K.U., and Rathinavelan, T. (2020). K-PAM: A unified platform to distinguish Klebsiella species K- and O-antigen types, model antigen structures and identify hypervirulent strains. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-73360-1"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"L\u00f8chen, A., Croucher, N.J., and Anderson, R.M. (2020). Divergent serotype replacement trends and increasing diversity in pneumococcal disease in high income settings reduce the benefit of expanding vaccine valency. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-75691-5"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0140-6736(05)65585-7","article-title":"Carriage of pneumococci after pneumococcal vaccination","volume":"348","author":"Obaro","year":"1996","journal-title":"Lancet"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(10)62225-8","article-title":"Serotype replacement in disease after pneumococcal vaccination","volume":"378","author":"Weinberger","year":"2011","journal-title":"Lancet"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41541-018-0090-4","article-title":"A recombinant conjugated pneumococcal vaccine that protects against murine infections with a similar efficacy to Prevnar-13","volume":"3","author":"Reglinski","year":"2018","journal-title":"npj Vaccines"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"18655","DOI":"10.1073\/pnas.1907833116","article-title":"A promising bioconjugate vaccine against hypervirulent Klebsiella pneumoniae","volume":"116","author":"Feldman","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Cuccui, J., Thomas, R.M., Moule, M.G., D\u2019Elia, R.V., Laws, T.R., Mills, D.C., Williamson, D., Atkins, T.P., Prior, J.L., and Wren, B.W. (2013). Exploitation of bacterial N-linked glycosylation to develop a novel recombinant glycoconjugate vaccine against Francisella tularensis. Open Biol., 3.","DOI":"10.1098\/rsob.130002"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2859-9-61","article-title":"Production of glycoprotein vaccines in Escherichia coli","volume":"9","author":"Ihssen","year":"2010","journal-title":"Microb. Cell Fact."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Wang, Y., Perepelov, A.V., Senchenkova, S.N., Lu, G., Wang, X., Ma, G., Yang, Q., Yuan, J., Wang, Y., and Xie, L. (2023). Glycoengineering directs de novo biomanufacturing of UPEC O21 O-antigen polysaccharide-based glycoprotein. Int. J. Biol. Macromol., 253.","DOI":"10.1016\/j.ijbiomac.2023.126993"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Williams, A.J., Warfel, K.F., Desai, P., Li, J., Lee, J.J., Wong, D.A., Nguyen, P.M., Qin, Y., Sobol, S.E., and Jewett, M.C. (2023). A low-cost recombinant glycoconjugate vaccine confers immunogenicity and protection against enterotoxigenic Escherichia coli infections in mice. Front. Mol. Biosci., 10.","DOI":"10.3389\/fmolb.2023.1085887"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12934-023-02099-x","article-title":"Preparation of a Klebsiella pneumoniae conjugate nanovaccine using glycol-engineered Escherichia coli","volume":"22","author":"Liu","year":"2023","journal-title":"Microb. Cell Fact."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Li, S., Huang, J., Wang, K., Liu, Y., Guo, Y., Li, X., Wu, J., Sun, P., Wang, Y., and Zhu, L. (2023). A bioconjugate vaccine against Brucella abortus produced by engineered Escherichia coli. Front. Bioeng. Biotechnol., 11.","DOI":"10.3389\/fbioe.2023.1121074"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/infdis\/jiae097","article-title":"Heptavalent O-Antigen Bioconjugate Vaccine Exhibiting Differential Functional Antibody Responses Against Diverse Klebsiella pneumoniae Isolates","volume":"230","author":"Wantuch","year":"2024","journal-title":"J. Infect. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41541-025-01068-2","article-title":"A platform for the recombinant production of Group A Streptococcus glycoconjugate vaccines","volume":"10","author":"Castro","year":"2025","journal-title":"npj Vaccines"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1093\/nar\/gky1182","article-title":"Start-Stop Assembly: A functionally scarless DNA assembly system optimized for metabolic engineering","volume":"47","author":"Taylor","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/glycob\/cwac082","article-title":"A combinatorial DNA assembly approach to biosynthesis of N-linked glycans in E. coli","volume":"33","author":"Passmore","year":"2023","journal-title":"Glycobiology"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Harrison, M.A., Atkins, E., Faulds-Pain, A., Heap, J.T., Wren, B.W., and Passmore, I.J. (2025). Modular Combinatorial DNA Assembly of Group B Streptococcus Capsular Polysaccharide Biosynthesis Pathways to Expediate the Production of Novel Glycoconjugate Vaccines. Vaccines, 13.","DOI":"10.3390\/vaccines13030279"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Valenzuela-Ortega, M., and French, C. (2021). Joint universal modular plasmids (JUMP): A flexible vector platform for synthetic biology. Synth. Biol., 6.","DOI":"10.1093\/synbio\/ysab003"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Jones, J.A., Vernacchio, V.R., Lachance, D.M., Lebovich, M., Fu, L., Shirke, A.N., Schultz, V.L., Cress, B., Linhardt, R.J., and Koffas, M.A.G. (2015). EPathOptimize: A combinatorial approach for transcriptional balancing of metabolic pathways. Sci. Rep., 5.","DOI":"10.1038\/srep11301"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-022-00497-7","article-title":"Rapid generation of Shigella flexneri GMMA displaying natural or new and cross-reactive O-Antigens","volume":"7","author":"Gasperini","year":"2022","journal-title":"npj Vaccines"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Micoli, F., Adamo, R., and Costantino, P. (2018). Protein carriers for glycoconjugate vaccines: History, selection criteria, characterization and new trends. Molecules, 23.","DOI":"10.3390\/molecules23061451"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/glycob\/cwq192","article-title":"Desulfovibrio desulfuricans PglB homolog possesses oligosaccharyltransferase activity with relaxed glycan specificity and distinct protein acceptor sequence requirements","volume":"21","author":"Ielmini","year":"2011","journal-title":"Glycobiology"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Ollis, A.A., Chai, Y., Natarajan, A., Perregaux, E., Jaroentomeechai, T., Guarino, C., Smith, J., Zhang, S., and DeLisa, M.P. (2015). Substitute sweeteners: Diverse bacterial oligosaccharyltransferases with unique N-glycosylation site preferences. Sci. Rep., 5.","DOI":"10.1038\/srep15237"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1099\/13500872-141-5-1247","article-title":"PilO, a gene required for glycosylation of Pseudomonas aeruginosa 1244 pilin","volume":"141","author":"Castric","year":"1995","journal-title":"Microbiology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"8088","DOI":"10.1128\/JB.01318-07","article-title":"Functional characterization of bacterial oligosaccharyltransferases involved in O-linked protein glycosylation","volume":"189","author":"Faridmoayer","year":"2007","journal-title":"J. Bacteriol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/mmi.12986","article-title":"Fiester, S.E.; Actis, L.A.; Tracy, E.N.; Munson, R.S.; et al. Acinetobacter strains carry two functional oligosaccharyltransferases, one devoted exclusively to type IV pilin, and the other one dedicated to O-glycosylation of multiple proteins","volume":"96","author":"Harding","year":"2015","journal-title":"Mol. Microbiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1073\/pnas.0809504106","article-title":"Broad spectrum O-linked protein glycosylation in the human pathogen Neisseria gonorrhoeae","volume":"106","author":"Vik","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"5972","DOI":"10.1128\/JB.00007-10","article-title":"Glycosylation of pilin and non-pilin protein constructs by Pseudomonas aeruginosa 1244","volume":"192","author":"Qutyan","year":"2010","journal-title":"J. Bacteriol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Pan, C., Sun, P., Liu, B., Liang, H., Peng, Z., Dong, Y., Wang, D., Liu, X., Wang, B., and Zeng, M. (2016). Biosynthesis of conjugate vaccines using an O-linked glycosylation system. mBio, 7.","DOI":"10.1128\/mBio.00443-16"},{"key":"ref_48","first-page":"1192","article-title":"A minimal sequon sufficient for O-linked glycosylation by the versatile oligosaccharyltransferase PglS","volume":"31","author":"Knoot","year":"2021","journal-title":"Glycobiology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1128\/AEM.01901-10","article-title":"Production of secretory and extracellular N-linked glycoproteins in Escherichia coli","volume":"77","author":"Fisher","year":"2011","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"ofad417","DOI":"10.1093\/ofid\/ofad417","article-title":"Safety, Reactogenicity, Immunogenicity, and Dose Selection of 10-Valent Extraintestinal Pathogenic Escherichia coli Bioconjugate Vaccine (VAC52416) in Adults Aged 60-85 Years in a Randomized, Multicenter, Interventional, First-in-Human, Phase 1\/2a Study","volume":"10","author":"Fierro","year":"2023","journal-title":"Open Forum Infect. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Clarkson, K.A., Talaat, K.R., Alaimo, C., Martin, P., Bourgeois, A.L., Dreyer, A., Porter, C.K., Chakraborty, S., Brubaker, J., and Elwood, D. (2021). Immune response characterization in a human challenge study with a Shigella flexneri 2a bioconjugate vaccine. eBioMedicine, 66.","DOI":"10.1016\/j.ebiom.2021.103308"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Duke, J.A., Paschall, A.V., Robinson, L.S., Knoot, C.J., Vinogradov, E., Scott, N.E., Feldman, M.F., Avci, F.Y., and Harding, C.M. Development and Immunogenicity of a Prototype Multivalent Group B Streptococcus Bioconjugate Vaccine. ACS Infect. Dis., 2021.","DOI":"10.1021\/acsinfecdis.1c00415"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41541-017-0037-1","article-title":"Design and production of conjugate vaccines against S. Paratyphi  A using an O-linked glycosylation system in vivo","volume":"3","author":"Sun","year":"2018","journal-title":"npj Vaccines"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Micoli, F., Stefanetti, G., and MacLennan, C.A. (2023). Exploring the variables influencing the immune response of traditional and innovative glycoconjugate vaccines. Front. Mol. Biosci., 10.","DOI":"10.3389\/fmolb.2023.1201693"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41541-021-00409-1","article-title":"Combined effects of glycan chain length and linkage type on the immunogenicity of glycoconjugate vaccines","volume":"6","author":"Anish","year":"2021","journal-title":"npj Vaccines"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"8087916","DOI":"10.1155\/2018\/8087916","article-title":"An O-Antigen glycoconjugate vaccine produced using protein glycan coupling technology is protective in an inhalational rat model of tularemia","volume":"2018","author":"Marshall","year":"2018","journal-title":"J. Immunol. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1073\/pnas.1816401115","article-title":"Polysaccharide structure dictates mechanism of adaptive immune response to glycoconjugate vaccines","volume":"116","author":"Sun","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.4049\/jimmunol.135.4.2319","article-title":"Carrier-induced epitopic suppression, a major issue for future synthetic vaccines","volume":"135","author":"Schutze","year":"1985","journal-title":"J. Immunol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Wang, Y., Liu, H., Wang, B., Gheyret, G., Qin, J., Wang, H., Di, Y., Wang, Y., Wang, J., and Tan, H. (2025). Recent advances in the biosynthesis of polysaccharide-based antimicrobial glycoconjugate vaccines. Front. Microbiol., 15.","DOI":"10.3389\/fmicb.2024.1457908"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1016\/S0264-410X(00)00554-5","article-title":"Reverse vaccinology, a genome-based approach to vaccine development","volume":"19","author":"Rappuoli","year":"2001","journal-title":"Vaccine"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nature12966","article-title":"Proof of principle for epitope-focused vaccine design","volume":"507","author":"Correia","year":"2014","journal-title":"Nature"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.coi.2011.04.006","article-title":"High throughput cellular screens to interrogate the human T and B cell repertoires","volume":"23","author":"Corti","year":"2011","journal-title":"Curr. Opin. Immunol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1084\/jem.20151960","article-title":"Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design","volume":"213","author":"Rappuoli","year":"2016","journal-title":"J. Exp. Med."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Goodswen, S.J., Kennedy, P.J., and Ellis, J.T. (2023). A guide to current methodology and usage of reverse vaccinology towards in silico vaccine discovery. FEMS Microbiol. Rev., 47.","DOI":"10.1093\/femsre\/fuad004"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Masignani, V., Pizza, M., and Moxon, E.R. (2019). The development of a vaccine against Meningococcus B using reverse vaccinology. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.00751"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"9072","DOI":"10.1073\/pnas.0915077107","article-title":"Identification of protective and broadly conserved vaccine antigens from the genome of extraintestinal pathogenic Escherichia coli","volume":"107","author":"Moriel","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13073-020-00824-4","article-title":"Taghavian, O.; Werner, E.; The, H.C.; Thu, T.N.H.; Duong, V.T.; Davies, D.H.; Felgner, P.L.; Baker, S. The identification of novel immunogenic antigens as potential Shigella vaccine components","volume":"13","author":"Liang","year":"2021","journal-title":"Genome Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1126\/science.1109869","article-title":"Identification of a Universal Group B Streptococcus Vaccine by Multiple Genome Screen","volume":"309","author":"Maione","year":"2005","journal-title":"Science"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1475-2859-6-3","article-title":"Identification of novel immunogens in Pasteurella multocida","volume":"6","author":"Boyce","year":"2007","journal-title":"Microb. Cell Fact."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Muruato, L.A., Tapia, D., Hatcher, C.L., Kalita, M., Brett, P.J., Gregory, A.E., Samuel, J.E., Titball, R.W., and Torres, A.G. (2017). Use of reverse vaccinology in the design and construction of nanoglycoconjugate vaccines against Burkholderia pseudomallei. Clin. Vaccine Immunol., 24.","DOI":"10.1128\/CVI.00206-17"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nrmicro2383","article-title":"Protein glycosylation in bacteria: Sweeter than ever","volume":"8","author":"Nothaft","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/nchembio.921","article-title":"An engineered eukaryotic protein glycosylation pathway in Escherichia coli","volume":"8","author":"Fisher","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/jphp.12321","article-title":"Hijacking bacterial glycosylation for the production of glycoconjugates, from vaccines to humanised glycoproteins","volume":"67","author":"Cuccui","year":"2015","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature10151","article-title":"X-ray structure of a bacterial oligosaccharyltransferase","volume":"474","author":"Lizak","year":"2011","journal-title":"Nature"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"15237","DOI":"10.1074\/jbc.RA119.009894","article-title":"Group A, B, C, and G Streptococcus Lancefield antigen biosynthesis is initiated by a conserved \u03b1-D-GlcNAc-\u03b2-1,4-L-rhamnosyltransferase","volume":"294","author":"Zorzoli","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1021\/bi602633n","article-title":"From Peptide to Protein: Comparative Analysis of the Substrate Specificity of N-Linked Glycosylation in C. jejuni","volume":"46","author":"Chen","year":"2007","journal-title":"Biochemistry"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"34596","DOI":"10.1074\/jbc.M807113200","article-title":"Extreme substrate promiscuity of the Neisseria oligosaccharyl transferase involved in protein O-glycosylation","volume":"283","author":"Faridmoayer","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Schulz, B.L., Jen, F.E.C., Power, P.M., Jones, C.E., Fox, K.L., Ku, S.C., Blanchfield, J.T., and Jennings, M.P. (2013). Identification of Bacterial Protein O-Oligosaccharyltransferases and Their Glycoprotein Substrates. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0062768"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.bbrc.2006.06.182","article-title":"Pilin glycosylation in Neisseria meningitidis occurs by a similar pathway to wzy-dependent O-antigen biosynthesis in Escherichia coli","volume":"347","author":"Power","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/s41467-019-08869-9","article-title":"A platform for glycoengineering a polyvalent pneumococcal bioconjugate vaccine using E. coli as a host","volume":"10","author":"Harding","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1128\/IAI.70.6.2837-2845.2002","article-title":"Identification of the Pseudomonas aeruginosa 1244 pilin glycosylation site","volume":"70","author":"Comer","year":"2002","journal-title":"Infect. Immun."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/glycob\/cwac070","article-title":"Discovery and characterization of a new class of O-linking oligosaccharyltransferases from the Moraxellaceae family","volume":"33","author":"Knoot","year":"2023","journal-title":"Glycobiology"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12934-015-0195-7","article-title":"In vivo production of a novel glycoconjugate vaccine against Shigella flexneri 2a in recombinant Escherichia coli: Identification of stimulating factors for in vivo glycosylation","volume":"14","author":"Braun","year":"2015","journal-title":"Microb. Cell Fact."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12934-024-02339-8","article-title":"Engineering Escherichia coli for increased Und-P availability leads to material improvements in glycan expression technology","volume":"23","author":"Kay","year":"2024","journal-title":"Microb. Cell Fact."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1002\/bit.23011","article-title":"Improving N-glycosylation efficiency in Escherichia coli using shotgun proteomics, metabolic network analysis, and selective reaction monitoring","volume":"108","author":"Pandhal","year":"2011","journal-title":"Biotechnol. Bioeng."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1002\/bit.24920","article-title":"Inverse metabolic engineering to improve Escherichia coli as an N-glycosylation host","volume":"110","author":"Pandhal","year":"2013","journal-title":"Biotechnol. Bioeng."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.bbrc.2017.11.023","article-title":"Producing a glycosylating Escherichia coli cell factory: The placement of the bacterial oligosaccharyl transferase pglB onto the genome","volume":"495","author":"Strutton","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12934-023-02125-y","article-title":"Development of a novel glycoengineering platform for the rapid production of conjugate vaccines","volume":"22","author":"Abouelhadid","year":"2023","journal-title":"Microb. Cell Fact."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ymben.2019.02.002","article-title":"Glyco-recoded Escherichia coli: Recombineering-based genome editing of native polysaccharide biosynthesis gene clusters","volume":"53","author":"Yates","year":"2019","journal-title":"Metab. Eng."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12934-022-01792-7","article-title":"Engineering a suite of E. coli strains for enhanced expression of bacterial polysaccharides and glycoconjugate vaccines","volume":"21","author":"Kay","year":"2022","journal-title":"Microb. Cell Fact."},{"key":"ref_91","first-page":"51","article-title":"Purification and characterization of a Shigella conjugate vaccine, produced by glycoengineering Escherichia coli","volume":"26","author":"Ravenscroft","year":"2016","journal-title":"Glycobiology"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/glycob\/cwz044","article-title":"Characterization and immunogenicity of a Shigella flexneri 2a O-antigen bioconjugate vaccine candidate","volume":"29","author":"Ravenscroft","year":"2019","journal-title":"Glycobiology"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/infdis\/jit800","article-title":"Prevention of Staphylococcus aureus infections by glycoprotein vaccines synthesized in Escherichia coli","volume":"209","author":"Wacker","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1128\/CVI.00224-16","article-title":"Safety and immunogenicity of a candidate bioconjugate vaccine against Shigella flexneri 2a administered to healthy adults: A single-blind, randomized phase I study","volume":"23","author":"Riddle","year":"2016","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41541-024-00885-1","article-title":"A randomized phase 1\/2a trial of ExPEC10V vaccine in adults with a history of UTI","volume":"9","author":"Fierro","year":"2024","journal-title":"npj Vaccines"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/13\/7\/703\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:00:53Z","timestamp":1760032853000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/13\/7\/703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,28]]},"references-count":95,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["vaccines13070703"],"URL":"https:\/\/doi.org\/10.3390\/vaccines13070703","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,28]]}}}